Ipratropium Bromide Flashcards
Generic Name:
Ipratropium Bromide
Trade Name:
Atrovent
Class:
Anticholinergic, bronchodilator
Supplied:
0.5 mg/2.5mL
Mechanism of Action:
Anticholinergic (parasympatholytic) agent appears to inhibit vagally-mediated reflexes by antagonizing the action of acetylcholine, the transmitter released from the vagal nerve. (SEE: Notes)
Indications and Field Use:
Treatment of bronchospasm associated with chronic obstructive pulmonary disease (emphysema and chronic bronchitis). To be used either alone or in combination with other bronchodilators especially beta adrenergics (i.e., albuterol).
Contraindications:
Ipratropium bromide is contraindicated in known or suspected cases of hypersensitivity to ipratropium bromide or to atropine and its derivatives. Precaution: should be used with caution in patients with narrow angle glaucoma.
Adverse Reactions:
Resp: Coughing. Sputum increased.
CNS: Dizziness. Insomnia. Tremor. Nervousness
GI: Nausea
Incompatibilities/Drug Interactions:
None. Ipratropium bromide has been shown to be safe and effective bronchodilator when used in conjunction with beta adrenergic bronchodilators (albuterol).
Adult Dosage:
Give 500 mcg in 2.5 ml normal saline (1 unit dose vial) via SVN with a mouth piece or in-line with a ventilatory device. Repeat according to medical control preference. May mix one unit dose vial of ipratropium with one unit dose vial of albuterol.
Pediatric Dosage:
Give 500 mcg in 2.5 ml normal saline (1 unit dose vial) via SVN with a mouth piece or in-line with a ventilatory device. Do not repeat.
Routes of Administration:
- Nebulized, mouth piece or in-line
- Inhaler, patients own
Onset of Action:
5 to 15 minutes
Peak Effects:
60 to 120 minutes
Duration of Action:
4 to 8 hours